L&C Bio fixes rights offering price at KRW 39,100 per share

• L&C Bio corrected its July 31 filing on a paid-in capital increase, confirming the final offer price at 39,100 won per share.
• The paid-in rights offering covers 3,700,000 common shares, targeting 105 billion won for facilities, 24.67 billion won for working capital.
• Listing of the paid-in new shares was shifted to Nov. 4, 2026 from Nov. 3, 2026.
• Listing of the bonus issue shares was moved to Nov. 12, 2026 from Nov. 11, 2026.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. L&C Bio Co. Ltd. published the original content used to generate this news brief via DART, the regulatory disclosure system operated by the South Korea Financial Supervisory Service (FSS) (Ref. ID: 20261012000188), on October 12, 2026, and is solely responsible for the information contained therein.